Showing results (391-400 of 417) with videos related to
Sort By:
Pageof 42
The American Journal of Gastroenterology|November 8, 2023
Predictors of Respiratory Failure Development in a Multicenter Cohort of Inpatients With CirrhosisJasmohan S Bajaj, Patrick S Kamath, K Rajender Reddy, et al.Hepatology (Baltimore, Md.)|February 12, 2021
American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver DiseaseOren K Fix, Emily A Blumberg, Kyong-Mi Chang, et al.The New England Journal of Medicine|April 24, 2013
Sofosbuvir for previously untreated chronic hepatitis C infectionEric Lawitz, Alessandra Mangia, David Wyles, et al.The New England Journal of Medicine|May 6, 2014
ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCVPeter Ferenci, David Bernstein, Jacob Lalezari, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 21, 2019
Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected PatientsVincent Lo Re, Craig W Newcomb, Dena M Carbonari, et al.JAMA|May 6, 2015
Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infectionFred Poordad, William Sievert, Lindsay Mollison, et al.Pharmacoepidemiology and Drug Safety|June 27, 2013
Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed DatabaseVincent Lo Re, Kevin Haynes, David Goldberg, et al.Hepatology (Baltimore, Md.)|March 29, 2021
Risk of HCC With Hepatitis B Viremia Among HIV/HBV-Coinfected Persons in North AmericaH Nina Kim, Craig W Newcomb, Dean M Carbonari, et al.The New England Journal of Medicine|April 15, 2014
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infectionNezam Afdhal, K Rajender Reddy, David R Nelson, et al.The New England Journal of Medicine|April 12, 2014
Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosisKris V Kowdley, Stuart C Gordon, K Rajender Reddy, et al.Pageof 42